The role of cytoreductive nephrectomy for renal cell carcinoma in the era of targeted therapy

被引:3
|
作者
Chowdhury, Simon [1 ]
Harper, Peter G. [2 ]
Choueiri, Toni K.
机构
[1] Guys Hosp, Dept Med Oncol, London SE1 9RT, England
[2] Guys & St Thomas Hosp, Natl Hlth Serv Trust, London SE1 9RT, England
来源
NATURE CLINICAL PRACTICE ONCOLOGY | 2008年 / 5卷 / 12期
关键词
D O I
10.1038/ncponc1256
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:698 / 699
页数:2
相关论文
共 50 条
  • [21] Improved survival in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy in the era of targeted therapy
    Iori Sakai
    Hideaki Miyake
    Nobuyuki Hinata
    Masato Fujisawa
    International Journal of Clinical Oncology, 2014, 19 : 674 - 678
  • [22] Improved survival in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy in the era of targeted therapy
    Sakai, Iori
    Miyake, Hideaki
    Hinata, Nobuyuki
    Fujisawa, Masato
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (04) : 674 - 678
  • [23] The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in the targeted therapy and immunological therapy era: a systematic review and meta-analysis
    Chen, Bo
    Li, Jinze
    Huang, Yin
    Tang, Bo
    Jiang, Jinjiang
    Chen, Zeyu
    Li, Jin
    Wang, Puze
    Cao, Dehong
    Liu, Liangren
    Wei, Qiang
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (04) : 982 - 994
  • [24] Cytoreductive nephrectomy in advanced or metastatic renal cell carcinoma (mRCC): In the era of targeted strategies
    Toutziaris, C.
    Lontovinis, L.
    Tsoukalas, N.
    Radopoulos, D.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 78 : S26 - S26
  • [25] Role of cytoreductive nephrectomy in renal cell carcinoma
    Chiong, Edmund
    Wood, Christopher G.
    Margulis, Vitaly
    FUTURE ONCOLOGY, 2009, 5 (06) : 859 - 869
  • [26] A commentary on 'The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in the targeted therapy and immunological therapy era: a systematic review and meta-analysis'
    Chen, Liyao
    Liu, Yiqiang
    Yang, Jierui
    Guo, Aihua
    Zhou, Gaoyang
    INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (10) : 6825 - 6826
  • [27] Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy: Scientifically Relevant or Natural Selection? Reply
    Sun, Maxine
    Hanna, Nawar
    Quoc-Dien Trinh
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (11) : 1266 - 1267
  • [28] The independent oncological role for cytoreductive nephrectomy in metastatic renal cell carcinoma: Prognostic features in the era of targeted therapies
    Claeys, Tom
    Lumen, Nicolaas
    Kumps, Candy
    Praet, Marleen
    De Meerleer, Gert
    Rottey, Sylvie
    Ost, Piet
    Devisschere, Pieter
    Villeirs, Geert
    Fonteyne, Valerie
    Decaestecker, Karel
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (04) : 152.e13 - 152.e22
  • [29] Role of vaccine therapy for renal cell carcinoma in the era of targeted therapy
    Yoshimura, Kazuhiro
    Uemura, Hirotsugu
    INTERNATIONAL JOURNAL OF UROLOGY, 2013, 20 (08) : 744 - 755
  • [30] Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy
    Richey, S. L.
    Culp, S. H.
    Jonasch, E.
    Corn, P. G.
    Pagliaro, L. C.
    Tamboli, P.
    Patel, K. K.
    Matin, S. F.
    Wood, C. G.
    Tannir, N. M.
    ANNALS OF ONCOLOGY, 2011, 22 (05) : 1048 - 1053